Sanofi ex­tends com­mit­ment to $750M biotech start­up fund

Last year, Sanofi’s ven­ture arm was very busy tak­ing the lead or par­tic­i­pat­ing in the fund­ing rounds of sev­er­al biotechs, and that ac­tiv­i­ty will not be stop­ping any time soon.

The French phar­ma an­nounced on Wednes­day it has placed an ad­di­tion­al mul­ti-year com­mit­ment in­to Sanofi Ven­tures, with over $750 mil­lion in the ven­ture arm’s cof­fers.

The in­jec­tion of funds will aim to ex­pand the “in­vest­ment ca­pac­i­ty” of Sanofi Ven­tures, which helps bankroll drug de­vel­op­ers and dig­i­tal health up­starts, start­ing as ear­ly as the seed stage. A Sanofi spokesper­son de­clined to dis­close the orig­i­nal size of the fund.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER